RAPTIVA SubQ

RAPTIVA SubQ Uses

This medication is used to treat adults with moderate to severe plaque psoriasis. Discuss risks and benefits of treatment and other possible medication options with your doctor.

This drug is a man-made protein (monoclonal antibody) that decreases the actions of certain immune system cells (T lymphocytes). This action decreases the skin changes that are seen with plaque psoriasis.

This drug has been withdrawn from the Canadian market due to problems with safety (see Warning section - PML).

How To Use RAPTIVA SubQ

Read the Patient Information Leaflet provided by your pharmacist before you start using efalizumab and each time you get a refill. If you have any questions regarding the information, consult your doctor or pharmacist.

Give this medication by injecting under the skin (subcutaneously-SC) of the thigh, abdomen, buttock, or upper arm, once a week; or use as directed by your doctor.

Your dose of efalizumab is based on your weight. Tell your doctor if your weight changes. Do not change your dose or stop taking this medication without talking to your doctor.

Follow all instructions for preparing this drug for injection. Gently swirl the vial to mix the drug. Do not shake. If you have questions regarding the use of this medication, consult your pharmacist.

Before injecting each dose, clean the injection site with rubbing alcohol. It is important to change the location of the injection site weekly.

Before using, check this product visually for particles or discoloration. If either is present, do not use the liquid.

Use this medication regularly in order to get the most benefit from it. Remember to use it on the same day each week.

It may take up to four weeks before the full benefits of this drug take effect. If your condition does not improve or worsens, contact your doctor.

Learn how to store and discard needles and medical supplies safely. Consult your pharmacist.

Next Section

Dosage and Storage